Results demonstrate the ability of the materials developed to form a shear-thinning hydrogel upon mixing, flow for injection delivery, and recover at the target site. Furthermore, biophysical properties of the injected hydrogel are controllable through the incorporation of secondary covalent crosslinking which is tailored to proceed at a clinically relevant time-scale. Ongoing work includes examination of hydrogel degradation in vivo, as well as implementing towards specific biomedical applications.
展开▼
